Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cytek Biosciences (CTKB) Preferred Dividend Payments (2020 - 2021)

Cytek Biosciences' Preferred Dividend Payments history spans 2 years, with the latest figure at -$1.2 million for Q4 2021.

  • For Q4 2021, Preferred Dividend Payments fell 104.35% year-over-year to -$1.2 million; the TTM value through Dec 2022 reached -$1.2 million, down 103.98%, while the annual FY2021 figure was $3.0 million, 81.47% down from the prior year.
  • Preferred Dividend Payments reached -$1.2 million in Q4 2021 per CTKB's latest filing, down from $1.1 million in the prior quarter.
  • In the past five years, Preferred Dividend Payments ranged from a high of $27.4 million in Q4 2020 to a low of -$6.2 million in Q2 2020.